Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Astria Therapeutics, Inc. - Common Stock (NQ:ATXS)

12.91 -0.06 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,058,125
Open 13.01
Bid (Size) 10.76 (100)
Ask (Size) 13.20 (300)
Prev. Close 12.97
Today's Range 12.89 - 13.04
52wk Range 3.555 - 13.29
Shares Outstanding 56,434,219
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Q3 2025 Earnings Miss, Focus Remains on Pending Acquisition and Pipeline ↗
Astria Therapeutics missed Q3 2025 earnings and revenue estimates, but the stock's focus remains on its promising HAE drug pipeline and the pending acquisition by BioCryst. 
Via Chartmill
Topics Earnings

Performance

YTD
+43.9%
+43.9%
1 Month
+2.4%
+2.4%
3 Month
+72.4%
+72.4%
6 Month
+123.0%
+123.0%
1 Year
+27.1%
+27.1%

More News

Read More
News headline image
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
From Astria Therapeutics, Inc.
Via Business Wire
BioCryst Stock Tumbles On Astria Buyout, But Analysts Stay Bullish — Retail Cheers The Move As Long-Term Play ↗
Via Stocktwits
BioCryst To Acquire Astria Therapeutics In $700M Deal ↗
Via Stocktwits
News headline image
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
From Astria Therapeutics, Inc.
Via Business Wire
News headline image
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
From Astria Therapeutics, Inc.
Via Business Wire
News headline image
HALPER SADEH LLC ENCOURAGES PLYM, HOLX, ATXS, PCH SHAREHOLDERS to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Unusual volume stocks in Monday's session ↗
Via Chartmill
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates RYN, PCH, ATXS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Astria Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ATXS and RYN on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate' ↗
Via Benzinga
News headline image
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Astria Therapeutics, Inc. - Common Stock publicly traded?
Yes, Astria Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Astria Therapeutics, Inc. - Common Stock trade on?
Astria Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Astria Therapeutics, Inc. - Common Stock?
The ticker symbol for Astria Therapeutics, Inc. - Common Stock is ATXS on the Nasdaq Stock Market
What is the current price of Astria Therapeutics, Inc. - Common Stock?
The current price of Astria Therapeutics, Inc. - Common Stock is 12.91
When was Astria Therapeutics, Inc. - Common Stock last traded?
The last trade of Astria Therapeutics, Inc. - Common Stock was at 12/11/25 04:00 PM ET
What is the market capitalization of Astria Therapeutics, Inc. - Common Stock?
The market capitalization of Astria Therapeutics, Inc. - Common Stock is 728.57M
How many shares of Astria Therapeutics, Inc. - Common Stock are outstanding?
Astria Therapeutics, Inc. - Common Stock has 729M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.